Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Democratic Kansas Gov. Laura Kelly condemned Republican overreach in health care as she announced Wednesday evening a list of ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development ...